+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biocept Inc (BIOC) - Product Pipeline Analysis, 2021 Update

  • ID: 5367339
  • Company Profile
  • June 2021
  • 34 pages
  • GlobalData

FEATURED COMPANIES

  • Affymax Inc
  • AVIVA Biosciences Corp
  • Biological Dynamics Inc
  • Celula Inc
  • CoImmune Inc
  • Epic Sciences Inc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE, Target Selector, and CEE-Sure, platform modifies rare cell capture and analyses methods. It serves cancer diagnostic assays to oncologists and other physicians; hospitals, and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies; and clinical research organizations. Biocept is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biocept Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Affymax Inc
  • AVIVA Biosciences Corp
  • Biological Dynamics Inc
  • Celula Inc
  • CoImmune Inc
  • Epic Sciences Inc
  • MORE
Biocept Inc Company Overview
  • Biocept Inc Company Snapshot
  • Biocept Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biocept Inc - Pipeline Analysis Overview
  • Biocept Inc - Key Facts
  • Biocept Inc - Major Products and Services
  • Biocept Inc Pipeline Products by Development Stage
  • Biocept Inc Ongoing Clinical Trials by Trial Status
Biocept Inc Pipeline Products Overview
  • Companion Diagnostic Target Selector Test - SCLC
  • Companion Diagnostic Target Selector Test - SCLC Product Overview
  • MicroRNA Test - Lung Cancer
  • MicroRNA Test - Lung Cancer Product Overview
  • OncoCEE - CR (FISH)
  • OncoCEE - CR (FISH) Product Overview
  • preCEED
  • preCEED Product Overview
  • Target Selector CTC Test - ESR1
  • Target Selector CTC Test - ESR1 Product Overview
  • Target Selector CTC Test - ESR1 Clinical Trial
  • Target Selector ctDNA Test - ALK
  • Target Selector ctDNA Test - ALK Product Overview
  • Target Selector ctDNA Test - ALK Clinical Trial
  • Target Selector ctDNA Test - ESR1
  • Target Selector ctDNA Test - ESR1 Product Overview
Biocept Inc - Key Competitors

Biocept Inc - Key Employees

Biocept Inc - Locations and Subsidiaries
  • Head Office
Recent Developments
  • Biocept Inc, Recent Developments
  • Jun 15, 2021: Biocept receives more than 420,000 samples during first year of offering COVID-19 testing service
  • May 05, 2021: Biocept to Report First Quarter 2021 Financial Results and Host Investor Conference Call on May 12, 2021
  • Mar 22, 2021: Biocept to Report 2020 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 29, 2021
  • Dec 14, 2020: Biocept provides business update
  • Dec 01, 2020: While The U.S. faces insufficient COVID-19 testing volume, EIR Healthcare launches MedModLabs to expand access immediately
  • Oct 06, 2020: Biocept provides update on COVID-19 testing with more than 50,000 specimens received
  • Sep 23, 2020: Biocept announces the award of Japanese patent for primer-switch mutation detection and amplification improvement platform used to detect rare cell mutations in tissue, blood and cerebrospinal fluid
  • Aug 19, 2020: Biocept expands agreement with MultiPlan to include COVID-19 testing
  • Jun 05, 2020: Biocept to relocate corporate offices and CLIA-Certified Laboratory to New San Diego Location
  • Apr 29, 2020: Biocept to Release First Quarter 2020 Financial Results and Host Investor Conference Call on May 13, 2020
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Biocept Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Biocept Inc Pipeline Products by Equipment Type
  • Biocept Inc Pipeline Products by Indication
  • Biocept Inc Ongoing Clinical Trials by Trial Status
  • Biocept Inc, Key Facts
  • Biocept Inc, Major Products and Services
  • Biocept Inc Number of Pipeline Products by Development Stage
  • Biocept Inc Pipeline Products Summary by Development Stage
  • Biocept Inc Ongoing Clinical Trials by Trial Status
  • Biocept Inc Ongoing Clinical Trials Summary
  • Companion Diagnostic Target Selector Test - SCLC - Product Status
  • Companion Diagnostic Target Selector Test - SCLC - Product Description
  • MicroRNA Test - Lung Cancer - Product Status
  • MicroRNA Test - Lung Cancer - Product Description
  • OncoCEE - CR (FISH) - Product Status
  • OncoCEE - CR (FISH) - Product Description
  • preCEED - Product Status
  • preCEED - Product Description
  • Target Selector CTC Test - ESR1 - Product Status
  • Target Selector CTC Test - ESR1 - Product Description
  • Target Selector CTC Test - ESR1 - Biocept's Liquid Biopsy Platform to Evaluate Cerebrospinal Fluid of Breast Cancer Patients for Metastatic Biomarkers
  • Target Selector ctDNA Test - ALK - Product Status
  • Target Selector ctDNA Test - ALK - Product Description
  • Target Selector ctDNA Test - ALK - Evaluation of Liquid Biopsies in Localized and Advanced Lung Cancer Patients
  • Target Selector ctDNA Test - ESR1 - Product Status
  • Target Selector ctDNA Test - ESR1 - Product Description
Biocept Inc, Key Employees
  • Glossary
List of Figures
  • Biocept Inc Pipeline Products by Equipment Type
  • Biocept Inc Pipeline Products by Development Stage
  • Biocept Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Sonic Healthcare USA, Inc.
  • Epic Sciences Inc
  • CoImmune Inc
  • Celula Inc
  • Biological Dynamics Inc
  • AVIVA Biosciences Corp
  • Affymax Inc
Note: Product cover images may vary from those shown
Adroll
adroll